Caron A. Jacobson, MD, medical oncologist and assistant professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School, both in Boston. She is the medical director of the Immune Effector Cell Therapy Program at Dana-Farber, which houses its CAR T-cell program. Dr. Jacobson, who specializes in lymphoma treatment and is affiliated with Brigham and Women’s Hospital in Boston, is the principal investigator of CAR T-cell trials in lymphoma there and at Dana-Farber.
CAR T-cell therapy uses a patient's own T-cells to recognize and destroy tumor cells...and it's showing remarkable success.
